Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
about
Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgeryThe role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosisModern brain tumor imagingRecent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma PatientsCurrent Applications of MRI-Guided Laser Interstitial Thermal Therapy in the Treatment of Brain Neoplasms and Epilepsy: A Radiologic and Neurosurgical OverviewPermeability imaging in pediatric brain tumors.Perfusion MRI: the five most frequently asked clinical questions.Intracranial metastases: spectrum of MR imaging findings.Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature.Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.Principles of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging.ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.Radionecrosis after stereotactic radiotherapy for brain metastases.Metastasis in Adult Brain Tumors.MR spectroscopy in radiation injury.Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imagingGlioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imagingPerfusion CT imaging of brain tumors: an overview.Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice.Clinical applications of dynamic susceptibility contrast perfusion-weighted MR imaging in brain tumours.Neuroimaging findings of the post-treatment effects of radiation and chemotherapy of malignant primary glial neoplasmsThe effect of pulse sequence parameters and contrast agent dose on percentage signal recovery in DSC-MRI: implications for clinical applications.Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion.Evaluation of radiation necrosis and malignant glioma in rat models using diffusion tensor MR imaging.Accuracy of percentage of signal intensity recovery and relative cerebral blood volume derived from dynamic susceptibility-weighted, contrast-enhanced MRI in the preoperative diagnosis of cerebral tumoursDifferentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-AnalysisPhase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.A prospective pilot study of two-session Gamma Knife surgery for large metastatic brain tumors.Intra-Arterial MR Perfusion Imaging of Meningiomas: Comparison to Digital Subtraction Angiography and Intravenous MR Perfusion Imaging.The Role of MRgLITT in Overcoming the Challenges in Managing Infield Recurrence After Radiation for Brain Metastasis.The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression: A meta-analysis.Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification.Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidenceMRI perfusion in determining pseudoprogression in patients with glioblastoma.A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patientsDifferentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies
P2860
Q24186860-EF6BD3F5-9C15-47D1-A749-AA3A86A76DBCQ26825055-6C47C742-5AA1-4985-9255-A00E1A34D911Q27002344-B05E8B5F-489E-4E23-8EE0-99F812EAC063Q28066044-ED20CB29-FE1B-4994-B69E-13165AEF0A8CQ28083956-6943DE44-49DA-4E02-960C-31A63B189F0AQ30392559-DE9299C8-747D-4D91-A146-C997F5F2170FQ30416198-08637536-5515-4F9F-B08F-0B3CB66C8B3EQ30574051-16F171E8-F565-45DE-A627-519F4D0737A2Q30599841-541FFEF7-EBC5-4CA3-A732-87EE4BD6C88EQ30653828-FACCC47A-29FA-4110-9139-A74A2EC5A02EQ30818733-568E168A-D746-4182-A806-DC04A62FCA12Q30938805-81150ECD-2525-47ED-90B0-A42AED938395Q31095955-D986AFF3-F046-4125-8B3E-D41BEDB35E48Q31135280-59B5EEF0-751D-47C5-AE62-2CCC6E8EFB7EQ33430676-D3DF08FC-F9C6-4DF5-A3A1-625BAA158AA0Q33507482-3356F05A-36E8-49A9-9E35-AF1B03A1FEAAQ33525779-0C42D397-E8A8-4F03-B2D5-5CC4E53C1904Q33738599-A9C0BD85-42D1-4E06-9756-A6942CB44042Q33862844-3298F6EB-50B7-4690-97A1-3633B9120866Q34011150-ECE13235-7D73-4046-A06A-D0811C0622E9Q34369465-B46C479D-30A3-4282-85F4-6C5CDFE0FAA1Q35047706-FF5C692A-9120-4F9C-94FB-0507D071B241Q35170356-D418FB12-91D2-4A3C-92F8-3FC1234FF93AQ35713015-00D9C5CA-14E4-43B5-85C0-FB9D1AFDE70BQ35811181-6D1219D2-6C16-42D5-94DE-F423A3E6C1E7Q35888150-5942CC1B-EBE6-46E1-967A-6FD647F7D75AQ35911026-FA948920-3D4D-4722-8C8A-533DCD078692Q36048224-590CE843-4CC0-470D-9124-0ED6CD312AC1Q36110253-CEDAF359-B9B1-4D96-95DC-39AF823EBB25Q36179212-8FA7B989-7E6C-4CA2-8C3D-553CAABF1BD6Q36196959-F228A8C2-C64B-4F25-A3CA-2BE65B70681BQ36308850-F5D86692-9B21-4967-AFDE-60090391018BQ36459981-EA3F6C1A-A715-4371-AE77-17997405EAAEQ36501587-6734A3EE-5817-40BB-8F49-C688E95A5964Q36515232-4065F79C-6651-449A-BD3F-31CFE74D2A1EQ36585386-4AB4D04B-493C-4C60-8DEC-631550A4655DQ36893250-2AD02D88-0707-4AF2-AAEB-4DEC05BD4DA1Q37109256-4D42D06F-4B9F-4DC8-BA3B-F3245BCB71A4Q37212449-192C5AC2-0CFD-4E82-9AB4-6E26432F1CFAQ38074638-46C52BAA-CF67-4B09-9254-9055BCFB6A4E
P2860
Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Distinguishing recurrent intra ...... enhanced perfusion MR imaging.
@en
Distinguishing recurrent intra ...... enhanced perfusion MR imaging.
@nl
type
label
Distinguishing recurrent intra ...... enhanced perfusion MR imaging.
@en
Distinguishing recurrent intra ...... enhanced perfusion MR imaging.
@nl
prefLabel
Distinguishing recurrent intra ...... enhanced perfusion MR imaging.
@en
Distinguishing recurrent intra ...... enhanced perfusion MR imaging.
@nl
P2093
P2860
P356
P1476
Distinguishing recurrent intra ...... enhanced perfusion MR imaging.
@en
P2093
P2860
P304
P356
10.3174/AJNR.A1362
P577
2008-11-20T00:00:00Z